Summation Bio, Inc. — Form D
Summation Bio, Inc. of SOMERVILLE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-05. The offering totals $64.5M, of which $24.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-05
- Form: D
- Accession: 0001920601-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $64.5M
- Amount sold: $24.5M
- Remaining: $40.0M
- Investors: 17
- Date of first sale: 2022-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-440343
Issuer
- Name: Summation Bio, Inc.
- CIK: 0001920601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 519 SOMERVILLE AVE, NUM 326, SOMERVILLE, MA, 02143
- Phone: 617-863-3650
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Luc Dochez | Director | NEW YORK, NY |
| Reza Halse | Director | Somerville, MA |
| Adarsha Koirala | Director | Somerville, MA |
| Gerald Sewack | Director | Somerville, MA |
| Adarsha Koirala | Executive Officer | Somerville, MA |
More